JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanwood, G. D.
Right arrow Articles by McGonigle, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanwood, G. D.
Right arrow Articles by McGonigle, P.

Vol. 295, Issue 3, 1232-1240, December 2000

Differential Regulation of Dopamine D2 and D3 Receptors by Chronic Drug Treatments1

Gregg D. Stanwood2 , Irwin Lucki and Paul McGonigle3

Departments of Pharmacology (G.D.S., I.L., P.M.) and Psychiatry (I.L.), and Institute for Neurological Sciences (G.D.S., I.L., P.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Regulation of the expression of dopamine D2 and D3 receptors in the rat brain was examined using quantitative autoradiography after chronic (14 day) drug treatments designed to increase or decrease dopamine receptor stimulation. Reserpine treatment depleted endogenous dopamine by more than 90% and significantly increased the binding of [125I]NCQ 298 to D2 receptors in the nucleus accumbens, ventral pallidum, and substantia nigra. In contrast, this treatment significantly decreased the binding of [125I]7-OH-PIPAT to D3 receptors in each of these regions. Chronic stimulation of D2-like receptors with quinpirole (1 mg/kg/day) or 7-OH-DPAT (1 mg/kg/day) produced decreases in [125I]NCQ 298 binding in the nucleus accumbens, ventral pallidum, and substantia nigra as expected. As with depletion, chronic stimulation elicited an opposite response from D3 receptors with significant increases observed in the ventral pallidum and substantia nigra. D3 receptor expression in the nucleus accumbens was unchanged. Baclofen (30 mg/kg/day) or continuous administration of the psychomotor stimulant cocaine (20 mg/kg/day) produced no significant changes in D2 or D3 receptor binding in any region examined. Acute administration of the irreversible antagonist EEDQ (10 mg/kg) nearly eliminated D2 receptor binding in all regions, but inactivated D3 receptors only in the VP and SN, suggesting subtype-specific and region-specific differences in receptor occupancy. The existence of regional and subtype-specific heterogeneities in the regulation of these receptors supports the contention that despite their similar pharmacological profiles, D2 and D3 receptors may mediate different functional responses.


1 This work was supported by NS18591, MH51880, DA07421, and a National Science Foundation predoctoral fellowship awarded to G.D.S.

2 Current address: Dept. of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15261.

3 Current address: Neuroscience Division, Wyeth Research, Princeton, NJ 08543.


0022-3565/00/2953-1232$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
D. D. Kline, G. Hendricks, G. Hermann, R. C. Rogers, and D. L. Kunze
Dopamine Inhibits N-Type Channels in Visceral Afferents to Reduce Synaptic Transmitter Release Under Normoxic and Chronic Intermittent Hypoxic Conditions
J Neurophysiol, May 1, 2009; 101(5): 2270 - 2278.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Cervenka, S. E. Palhagen, R. A. Comley, G. Panagiotidis, Z. Cselenyi, J. C. Matthews, R. Y. Lai, C. Halldin, and L. Farde
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Brain, August 1, 2006; 129(8): 2017 - 2028.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. D. Stanwood, R. P. Artymyshyn, M.-P. Kung, H. F. Kung, I. Lucki, and P. McGonigle
Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1223 - 1231.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.